Cabazitaxel Teva Европска Унија - Летонски - EMA (European Medicines Agency)

cabazitaxel teva

teva b.v. - cabazitaxel - prostatas audzēji - antineoplastiski līdzekļi - Ārstēšana prostatas vēža.

Solumarv Европска Унија - Летонски - EMA (European Medicines Agency)

solumarv

marvel lifesciences ltd - cilvēka insulīns - cukura diabēts - diabēta ārstēšanā.

Lympreva Европска Унија - Летонски - EMA (European Medicines Agency)

lympreva

biovest europe ltd - dasiprotimut-t - limfoma, ne-hodžkina - suspensija injekcijām - Ārstēšana nav hodgkins limfomas (fl),.

Dovprela (previously Pretomanid FGK) Европска Унија - Летонски - EMA (European Medicines Agency)

dovprela (previously pretomanid fgk)

mylan ire healthcare limited - pretomanid - tuberkuloze, pret multidrugiem izturīga - antimikobaktērijas - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). jāņem vērā oficiālās vadlīnijas par piemērotu izmantot antibakteriālas vielas.

Alpheon Европска Унија - Летонски - EMA (European Medicines Agency)

alpheon

biopartners gmbh - recombinant human interferon alfa-2a - c hepatīts, hronisks - imunitātes stimulatori, - adult patients with histologically proven chronic hepatitis c who are positive for hepatitis c virus (hcv) antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation. the efficacy of interferon alfa-2a in the treatment of hepatitis c is enhanced when combined with ribavirin. alpheon should be given alone mainly in case of intolerance or contra-indication to ribavirin.